Interestingly, UroA has been shown to target and to block PI3K/Akt pathway in pancreatic cancer cell line in vitro (39) and to reduce the level of phosphorylated AKT in pancreatic tumors in vivo (20). The gene discussed is AKT1; the disease is pancreatic neoplasm.